---
category: news
title: "CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms"
excerpt: "CytoReason, an AI company developing a computational disease model of the human body for clinical drug development, today announced the initiation of a project with French global biopharmaceutical company Sanofi,"
publishedDateTime: 2021-06-17T13:49:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/cytoreason-collaborates-with-sanofi-using-its-ai-technology-to-gain-better-understanding-of-disease-mechanisms-1030532479"
webUrl: "https://markets.businessinsider.com/news/stocks/cytoreason-collaborates-with-sanofi-using-its-ai-technology-to-gain-better-understanding-of-disease-mechanisms-1030532479"
type: article
quality: 47
heat: 47
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1513066/CytoReason_Logo.jpg"
    width: 400
    height: 256
    isCached: true

secured: "2Z/XZvSOcEe0PY4kOwtCfRXUPCC9ONpsOPXUYRCp7l7lkTDf/XudtSObaaFOXe27M9wL0XMpy92Ad2cxHB9Hl1bUUGtTJJeygU+zgGjzXRRd8J8jbVW9tLxyhcR4G4mcKgka0hQ//CuPNaT2SMd5NoZD6lEEcMOr2oCbqUCTfvVMhE7q+Zon7bHRh8G+LDcDTViEFoh7GyXaC3Dj0fqhlYSqVsuNkgXOZQxSXUzaTQkz+qr52PDziL1ICgNnq7DB/0zJYqlceVxXJ5umNX6sZR3m3x2Z+XJBX15evrfr68dvoQEplDkKKe7KZGF7QuzL5a028e8y8eyB3w9BplxtzbD5aPXpMVCFY116nt4the0=;Kk0xPA0LJm4DhY7Yntc/QA=="
---

